IDHCX | RMEBX | IDHCX / RMEBX | |
Total Expense Ratio | 1.70 | 1.07 | 159% |
Annual Report Gross Expense Ratio | 2.21 | 1.07 | 207% |
Fund Existence | 10 years | 11 years | - |
Gain YTD | -6.866 | -6.103 | 113% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 440M | 93.9B | 0% |
Annual Yield % from dividends | 2.08 | 1.18 | 176% |
Returns for 1 year | -0.58 | -1.77 | 33% |
Returns for 3 years | 6.55 | 1.85 | 353% |
Returns for 5 years | 70.88 | 59.77 | 119% |
Returns for 10 years | N/A | 49.12 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AWIIX | 14.83 | -0.54 | -3.51% |
CIBC Atlas Income Opportunities Instl | |||
LKSMX | 10.01 | -0.51 | -4.85% |
LKCM Small-Mid Cap Equity Institutional | |||
TNBAX | 17.41 | -0.99 | -5.36% |
1290 SmartBeta Equity A | |||
DGAGX | 33.63 | -2.07 | -5.80% |
BNY Mellon Appreciation Investor | |||
JDESX | 37.34 | -2.36 | -5.94% |
JPMorgan US Research Enhanced Equity I |